Literature DB >> 25732644

Silent pituitary adenomas.

Sarah E Mayson1, Peter J Snyder2.   

Abstract

Pituitary adenomas are frequently silent. Among silent adenomas, some are clinically silent but can be detected on the basis of the excessive secretion of hormonal products, whereas others are totally silent and cannot be detected by hormonal measurements. Treatment of a silent pituitary adenoma depends on its size and extent. Silent adenomas that are associated with neurologic compromise should be treated by surgery. Postoperative radiation therapy may be used to prevent or treat recurrences. Only occasional silent pituitary adenomas respond to treatment with dopamine agonists or somatostatin analogs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinically silent pituitary adenoma; Nonfunctioning pituitary adenoma; Silent pituitary adenoma

Mesh:

Year:  2014        PMID: 25732644     DOI: 10.1016/j.ecl.2014.11.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  8 in total

1.  Pituitary Apoplexy With Bilateral Oculomotor Nerve Palsy.

Authors:  Sevan R Komshian; Ramin Saket; Khamid Bakhadirov
Journal:  Neurohospitalist       Date:  2018-05-07

2.  Aggressive somatotrophinomas lacking clinical symptoms: neurosurgical management.

Authors:  Mario Giordano; Amir Samii; Rudolf Fahlbusch
Journal:  Neurosurg Rev       Date:  2017-12-30       Impact factor: 3.042

3.  Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus.

Authors:  Hiromitsu Iwata; Kengo Sato; Ryutaro Nomura; Yusuke Tabei; Ichiro Suzuki; Naoki Yokota; Mitsuhiro Inoue; Seiji Ohta; Shozo Yamada; Yuta Shibamoto
Journal:  J Neurooncol       Date:  2016-03-09       Impact factor: 4.130

Review 4.  Non-functioning pituitary adenomas: growth and aggressiveness.

Authors:  Kristin Astrid Øystese; Johan Arild Evang; Jens Bollerslev
Journal:  Endocrine       Date:  2016-04-11       Impact factor: 3.633

5.  Retinal nerve fiber layer changes after transsphenoidal and transcranial pituitary adenoma resection.

Authors:  Nidan Qiao; Zhao Ye; Ming Shen; Xuefei Shou; Yongfei Wang; Shiqi Li; Min Wang; Yao Zhao
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

Review 6.  Histopathological classification of non-functioning pituitary neuroendocrine tumors.

Authors:  Emilija Manojlovic-Gacic; Britt Edén Engström; Olivera Casar-Borota
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

7.  Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas.

Authors:  Mohammad E Khamseh; Alireza Sheikhi; Zahra Shahsavari; Mohammad Ghorbani; Hamideh Akbari; Mehrnaz Imani; Mahshid Panahi; Alimohammad Alimohammadi; Maryam Ameri; Shima Nazem; Vahid Salimi; Masoumeh Tavakoli-Yaraki
Journal:  BMC Endocr Disord       Date:  2022-01-04       Impact factor: 2.763

8.  Function of cell-cycle regulators in predicting silent pituitary adenoma progression following surgical resection.

Authors:  Sung Hyun Park; Ji Hwan Jang; Young Min Lee; Joon Soo Kim; Kyu Hong Kim; Young Zoon Kim
Journal:  Oncol Lett       Date:  2017-10-02       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.